Sucampo Pharmaceuticals Inc (SCMP.OQ)

SCMP.OQ on NASDAQ Stock Exchange Global Market

26 Feb 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for SCMP.OQ


Sucampo Pharmaceuticals, Inc. is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company is focused on developing and/or commercializing prostone-based drugs to treat gastrointestinal, ophthalmic, neurologic, and... (more)


Beta: 1.57
Market Cap(Mil.): $695.84
Shares Outstanding(Mil.): 44.35
Dividend: --
Yield (%): --


  SCMP.OQ Industry Sector
P/E (TTM): 112.85 175.69 40.21
EPS (TTM): 0.14 -- --
ROI: 6.29 -2.62 16.34
ROE: 9.88 -4.38 17.27
Search Stocks

BRIEF-Takeda and Sucampo enter into global licensing agreement for Amitiza

* Takeda and Sucampo enter into global licensing agreement for Amitiza

21 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks